DOI : 10.1055/s-00000034

Klinische Pädiatrie

Issue 03 · Volume 225 · May 2013 DOI: 10.1055/s-003-25016


XXVI. Jahrestagung der Kind-Philipp-Stiftung für Leukämieforschung
Wilsede, Lüneburger Heide, 5.–8. Juni 2013

Wissenschaftliche Leitung: Prof. Dr. Martin Horstmann, Prof. Dr. Rolf Marschalek, Prof. Dr. Martin Stanulla
Abstracts (HTML) List of Authors
A1
Klimiankou, M; Kandabarau, S; Reuter, M; Hagemann, AL; Zeidler, C; Welte, K; Skokowa, J: Identification of new leukemia associated gene mutations by whole genome sequencing of DNA from two siblings with congenital neutropenia and secondary AML
A2
Elder, AK; Heidenreich, O; Vormoor, HJ: Cellular barcoding as a tool to investigate the clonal complexity and evolution of ALL
A3
Torge, A; Zimmermann, M; Möricke, A; Köhler, R; Schrauder, A; Bartram, CR; Schrappe, M; Stanulla, M: Prediction of minimal residual disease in pediatric ALL: Evaluation of the predictive potential of the variables from the ALL-BFM 2000 trial
A4
Samareh, B; Welte, K; Skokowa, J: Hematopoietic-specific lyn-substrate 1 (HCLS) is deacetylated by NAMPT/NAD+/SIRT1 pathway
A5
Dasci, F; Emmrich, S; Henke, K; Kuipers, J; Heuvel vd, M; Klusmann, JH: MiR-181a/b and -c/d act as tumor suppressors in MLL-rearranged leukemia by targeting the MLL-complex
A6
Schmidt, F; Emmrich, S; Klusmann, JH: Molecular characterization of lineage-specific long non-coding RNAs in hematopoiesis
A7
Tauer, JT; Jung, R; Suttorp, M: Long-term administration of the tyrosine kinase inhibitor bosutinib via micro-osmotic pumps and resulting skeletal side effects in juvenile rats
A8
Skokowa, J; Steinemann, D; Zeidler, C; Makaryan, V; Beekman, R; Klimiankou, M; Ünalan, M; Kandabarau, S; Schnittger, S; Kohlmann, A; Valkhof, MG; Hoogenboezem, R; Göhring, G; Schlegelberger, B; Stanulla, M; Vandenberghe, P; Donadieu, J; Touw, IP; Dale, DC; Welte, K: The Association of Mutations in RUNX1 and CSF3R with the Development of Leukemia in Severe Congenital Neutropenia: A unique pathway in leukemogenesis
A9
Dormon, K; Vormoor, J; Heidenreich, O: Darwinian Fitness of Acute Lymphoblastic Leukaemia
A10
Stachorski, L; Thangapandi, VR; Reinhardt, D; Klusmann, JH: Characterization of oncogenes on chromosome 21 identified by shRNA-based viability screening
A11
Martinez, N; Prall, S; Blair, H; Heidenreich, O: Relevance of RUNX1/ETO for Leukaemic Propagation in vivo
A12
Geidel, P; Tauer, JT; Steinbronn, N; Jung, R; Bonifacio, E; Leuschner, I; Strasser, RH; Suttorp, M: Continuous but not intermittent long-term exposure to the tyrosine kinase inhibitor (TKI) dasatinib causes cardiac failure in juvenile rats
A13
Jammal, R; Emmrich, S; Henke, K; Kuipers, J; Heuvel vd, M; Reinhardt, D; Klusmann, JH: High-throughput functional characterization of miRNAs in cytogenetically defined AML subgroups
A14
Meyer, C; Hofmann, J; Klingebiel, T; Dingermann, T; Marschalek, R: The MLL recombinome 2013: an update
A15
Krause, S; Strube, S; Stanulla, M; Schrappe, M; Schewe, D: TGF-β signaling causes ALL quiescence
A16
Fluhr, S; Witte, T; Krombholz, CF; Plass, C; Niemeyer, CM; Flotho, C: Prognostic relevance of disordered epigenetic regulation in juvenile myelomonocytic leukemia
A17
Strube, S; Krause, S; Stanulla, M; Schrappe, M; Schewe, D: p38α/β inhibition prevents ALL proliferation in vivo
A18
Bartram, T; Ellinghaus, E; Houlston, R; Zimmermann, M; Möricke, A; Cario, G; Franke, A; Schrappe, M; Stanulla, M: Identification of germline polymorphisms associated with clinical and toxicity phenotypes in childhood acute lymphoblastic leukemia
A19
Dertmann, T; Maroz, A; Klusmann, JH: Finding the molecular basis for developmental-stage specific differences in hematopoietic stem and progenitor cells
A20
Forster, V; Bradburn, AK; Garrido Castro, P; Allan, J; Heidenreich, O: AML1/ETO regulates the angiogenesis regulatory factor Angiopoietin-1